Company / Tangible Book Value per Share
ANI Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$22.66
FY2025
5-year range
$17.56 / $24.29
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#20 of 209
Health Care
What the data says
Among 209 Health Care companies, ANI Pharmaceuticals, Inc. is in the top 10% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $14.50 in FY2016 to $24.29 in FY2021.
Based on SEC 10-K filings.
22.66 in FY2025 with a 5-year CAGR of +7.1%. Top quartile in the Health Care sector.
Remained stable around $22.66 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +7.1%
- 10-Year CAGR
- -
Sector benchmark
-75.8% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 7.2% year-over-year.
- Ranks #20 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.66 | +7.2% |
| FY2024 | $21.14 | -4.9% |
| FY2023 | $22.23 | +26.6% |
| FY2022 | $17.56 | -27.7% |
| FY2021 | $24.29 | +51.3% |
| FY2020 | $16.06 | -11.4% |
| FY2019 | $18.12 | +10.1% |
| FY2018 | $16.45 | +10.0% |
| FY2017 | $14.96 | +3.2% |
| FY2016 | $14.50 | -99.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026